Summary
392.93 -0.35(-0.09%)05/17/2024
Medpace Holdings Inc (MEDP)
Medpace Holdings Inc (MEDP)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.44 | 3.51 | -1.62 | 30.15 | 46.51 | 91.95 | 602.62 | 1,347.21 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 402.18 | |
| Open | 400.50 | |
| High | 409.19 | |
| Low | 398.41 | |
| Volume | 158,607 | |
| Change | 1.77 | |
| Change % | 0.44 | |
| Avg Volume (20 Days) | 238,115 | |
| Volume/Avg Volume (20 Days) Ratio | 0.67 | |
| 52 Week Range | 197.39 - 421.00 | |
| Price vs 52 Week High | -4.47% | |
| Price vs 52 Week Low | 103.75% | |
| Range | 0.42 | |
| Gap Up/Down | -4.73 | |
Fundamentals | ||
| Market Capitalization (Mln) | 12,186 | |
| EBIDTA | 219,884,992 | |
| PE Ratio | 41.9255 | |
| PEG Ratio | 1.9700 | |
| WallStreet Target Price | 201.00 | |
| Book Value | 25.1180 | |
| Earnings Per Share | 4.8300 | |
| EPS Estimate Current Quarter | 1.0700 | |
| EPS Estimate Next Quarter | 1.1700 | |
| EPS Estimate Current Year | 4.7500 | |
| EPS Estimate Next Year | 5.4800 | |
| Diluted EPS (TTM) | 4.8300 | |
| Revenues | ||
| Profit Marging | 0.1671 | |
| Operating Marging (TTM) | 0.1818 | |
| Return on asset (TTM) | 0.0865 | |
| Return on equity (TTM) | 0.2162 | |
| Revenue TTM | 1,093,502,976 | |
| Revenue per share TTM | 30.5780 | |
| Quarterly Revenue Growth (YOY) | 0.2830 | |
| Quarterly Earnings Growth (YOY) | 0.1830 | |
| Gross Profit (TTM) | 571,499,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 41.9255 | |
| Forward PE | 40.9836 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 8.1900 | |
| Revenue Enterprise Value | 6.4793 | |
| EBITDA Enterprise Value | 32.2220 | |
| Shares | ||
| Shares Outstanding | 35,939,200 | |
| Shares Float | 29,200,090 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 19.40 | |
| Institutions (%) | 81.93 | |
05/17 08:11 EST - zacks.com
4 Best Momentum Stocks Worth a Buy Using Driehaus Strategy
Stocks like Wingstop (WING), Medpace (MEDP), Comfort Systems USA (FIX) and HCI Group (HCI) have been selected as the momentum picks for the day using the Driehaus strategy.
4 Best Momentum Stocks Worth a Buy Using Driehaus Strategy
Stocks like Wingstop (WING), Medpace (MEDP), Comfort Systems USA (FIX) and HCI Group (HCI) have been selected as the momentum picks for the day using the Driehaus strategy.
05/13 13:46 EST - zacks.com
3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)
Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)
Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
05/13 08:21 EST - zacks.com
5 Stocks With Upgraded Broker Ratings Worth Investing in Now
Brokers have deeper insights into stocks and macroeconomic factors. So, one should follow broker rating upgrades to pick stocks like Medpace (MEDP), American Axle & Manufacturing (AXL), Diebold Nixdorf (DBD), Euronet (EEFT) and Omnicom (OMC).
5 Stocks With Upgraded Broker Ratings Worth Investing in Now
Brokers have deeper insights into stocks and macroeconomic factors. So, one should follow broker rating upgrades to pick stocks like Medpace (MEDP), American Axle & Manufacturing (AXL), Diebold Nixdorf (DBD), Euronet (EEFT) and Omnicom (OMC).
05/10 10:47 EST - zacks.com
Are Medical Stocks Lagging Medpace (MEDP) This Year?
Here is how Medpace (MEDP) and Tenet Healthcare (THC) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Medpace (MEDP) This Year?
Here is how Medpace (MEDP) and Tenet Healthcare (THC) have performed compared to their sector so far this year.
05/09 10:01 EST - zacks.com
Medpace Holdings, Inc. (MEDP) Is a Trending Stock: Facts to Know Before Betting on It
Medpace (MEDP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Medpace Holdings, Inc. (MEDP) Is a Trending Stock: Facts to Know Before Betting on It
Medpace (MEDP) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
05/08 11:11 EST - zacks.com
5 Growth Stocks to Buy for Steady Returns in May
We have narrowed our search to five growth stocks that have solid upside left for 2024. These stocks are NFLX, WING, PATH, SKX and MEDP.
5 Growth Stocks to Buy for Steady Returns in May
We have narrowed our search to five growth stocks that have solid upside left for 2024. These stocks are NFLX, WING, PATH, SKX and MEDP.
05/03 10:31 EST - zacks.com
Brokers Suggest Investing in Medpace (MEDP): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Brokers Suggest Investing in Medpace (MEDP): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
04/25 13:45 EST - zacks.com
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.
Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"
Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.
04/25 12:11 EST - zacks.com
3 Medical Services Industry Stocks to Buy as Nursing Market Booms
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, MEDP and DOCS are set to gain the most.
3 Medical Services Industry Stocks to Buy as Nursing Market Booms
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, MEDP and DOCS are set to gain the most.
04/23 12:55 EST - seekingalpha.com
Medpace Holdings, Inc. (MEDP) Q1 2024 Earnings Call Transcript
Medpace Holdings, Inc. (NASDAQ:MEDP ) Q1 2024 Earnings Call Transcript April 23, 2024 9:00 AM ET Company Participants Lauren Morris - Director of IR Jesse Geiger - President Kevin Brady - CFO August Troendle - CEO Conference Call Participants Max Smock - William Blair Eric Coldwell - Baird Jack Wallace - Guggenheim Partners Dan Leonard - UBS Justin Bowers - Deutsche Bank David Windley - Jefferies Operator Good day, ladies and gentlemen, and welcome to Medpace First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Medpace Holdings, Inc. (MEDP) Q1 2024 Earnings Call Transcript
Medpace Holdings, Inc. (NASDAQ:MEDP ) Q1 2024 Earnings Call Transcript April 23, 2024 9:00 AM ET Company Participants Lauren Morris - Director of IR Jesse Geiger - President Kevin Brady - CFO August Troendle - CEO Conference Call Participants Max Smock - William Blair Eric Coldwell - Baird Jack Wallace - Guggenheim Partners Dan Leonard - UBS Justin Bowers - Deutsche Bank David Windley - Jefferies Operator Good day, ladies and gentlemen, and welcome to Medpace First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
04/22 18:25 EST - zacks.com
Medpace (MEDP) Beats Q1 Earnings Estimates
Medpace (MEDP) came out with quarterly earnings of $3.20 per share, beating the Zacks Consensus Estimate of $2.45 per share. This compares to earnings of $2.27 per share a year ago.
Medpace (MEDP) Beats Q1 Earnings Estimates
Medpace (MEDP) came out with quarterly earnings of $3.20 per share, beating the Zacks Consensus Estimate of $2.45 per share. This compares to earnings of $2.27 per share a year ago.
04/22 16:15 EST - businesswire.com
Medpace Holdings, Inc. Reports First Quarter 2024 Results
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Revenue for the three months ended March 31, 2024 increased 17.7% to $511.0 million, compared to $434.1 million for the comparable prior-year period. On a constant currency basis, revenue for the first quarter of 2024 increased 17.6% compared to the first quarter of 2023. Backlog as of March 31, 2024 inc.
Medpace Holdings, Inc. Reports First Quarter 2024 Results
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Revenue for the three months ended March 31, 2024 increased 17.7% to $511.0 million, compared to $434.1 million for the comparable prior-year period. On a constant currency basis, revenue for the first quarter of 2024 increased 17.6% compared to the first quarter of 2023. Backlog as of March 31, 2024 inc.
04/15 11:05 EST - zacks.com
Medpace (MEDP) Earnings Expected to Grow: Should You Buy?
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medpace (MEDP) Earnings Expected to Grow: Should You Buy?
Medpace (MEDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
04/05 13:16 EST - zacks.com
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report?
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
03/30 09:16 EST - investors.com
Uber Leads Five Stocks Near Buy Points
Uber, Axon and one more stock with the highest-possible rating from IBD lead this weekend's watch list.
Uber Leads Five Stocks Near Buy Points
Uber, Axon and one more stock with the highest-possible rating from IBD lead this weekend's watch list.
03/28 16:05 EST - businesswire.com
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you join 1.
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you join 1.
03/28 09:51 EST - zacks.com
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
03/05 07:11 EST - zacks.com
4 Best Profitable Stocks to Invest in Using Net Income Ratio
Trip.com Group Limited (TCOM), Medpace (MEDP), Centrus Energy (LEU) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.
4 Best Profitable Stocks to Invest in Using Net Income Ratio
Trip.com Group Limited (TCOM), Medpace (MEDP), Centrus Energy (LEU) and NVIDIA (NVDA) have been selected as the top picks with a high net income ratio.
03/04 13:46 EST - zacks.com
Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why
Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.
03/04 13:01 EST - zacks.com
Medpace (MEDP) Is Up 0.64% in One Week: What You Should Know
Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Medpace (MEDP) Is Up 0.64% in One Week: What You Should Know
Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.